161 related articles for article (PubMed ID: 24906877)
1. Prognostic impact of angiopoietin-2 in multiple myeloma.
Pappa CA; Alexandrakis MG; Boula A; Thanasia A; Konsolas I; Alegakis A; Tsirakis G
J Cancer Res Clin Oncol; 2014 Oct; 140(10):1801-5. PubMed ID: 24906877
[TBL] [Abstract][Full Text] [Related]
2. Emerging roles of endoglin/CD105 and angiogenic cytokines for disease development and progression in multiple myeloma patients.
Pappa CA; Alexandrakis MG; Boula A; Psarakis FE; Kolovou A; Bantouna V; Stavroulaki E; Tsirakis G
Hematol Oncol; 2013 Dec; 31(4):201-5. PubMed ID: 23576184
[TBL] [Abstract][Full Text] [Related]
3. Circulating angiopoietin-1 to angiopoietin-2 ratio is an independent prognostic factor for survival in newly diagnosed patients with multiple myeloma who received therapy with novel antimyeloma agents.
Terpos E; Anargyrou K; Katodritou E; Kastritis E; Papatheodorou A; Christoulas D; Pouli A; Michalis E; Delimpasi S; Gkotzamanidou M; Nikitas N; Koumoustiotis V; Margaritis D; Tsionos K; Stefanoudaki E; Meletis J; Zervas K; Dimopoulos MA;
Int J Cancer; 2012 Feb; 130(3):735-42. PubMed ID: 21484787
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of endoglin offers a reliable estimation of bone marrow neoangiogenesis in multiple myeloma.
Alexandrakis MG; Neonakis IK; Pappa CA; Konsolas I; Kokonozaki M; Vyzoukaki R; Soundoulounaki S; Xekalou A; Sfiridaki K; Tsirakis G
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1503-9. PubMed ID: 25773125
[TBL] [Abstract][Full Text] [Related]
5. Potential role of FLT3-ligand in the angiogenic process of multiple myeloma.
Kokonozaki M; Tsirakis G; Devetzoglou M; Kyriakaki S; Antonakis A; Vyzoukaki R; Pappa CA; Tzardi M; Alexandrakis MG
Leuk Res; 2015 Dec; 39(12):1467-72. PubMed ID: 26521986
[TBL] [Abstract][Full Text] [Related]
6. The significance of non correlation between interleukin-8 serum levels with bone marrow microvascular density in patients with myeloma multiple.
Pappa CA; Tsirakis G; Boula A; Sfiridaki A; Psarakis FE; Alexandrakis MG; Stathopoulos EN
Pathol Oncol Res; 2013 Jul; 19(3):539-43. PubMed ID: 23456515
[TBL] [Abstract][Full Text] [Related]
7. Role of platelet-derived growth factor-AB in tumour growth and angiogenesis in relation with other angiogenic cytokines in multiple myeloma.
Tsirakis G; Pappa CA; Kanellou P; Stratinaki MA; Xekalou A; Psarakis FE; Sakellaris G; Alegakis A; Stathopoulos EN; Alexandrakis MG
Hematol Oncol; 2012 Sep; 30(3):131-6. PubMed ID: 21919032
[TBL] [Abstract][Full Text] [Related]
8. Circulating serum levels of IL-20 in multiple myeloma patients: its significance in angiogenesis and disease activity.
Alexandrakis MG; Pappa CA; Kokonozaki M; Boula A; Vyzoukaki R; Staphylaki D; Papadopoulou A; Androulakis N; Tsirakis G; Sfiridaki A
Med Oncol; 2015 Mar; 32(3):42. PubMed ID: 25631632
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of angiopoietin-1, angiopoietin-2, and their receptor tie-2 in patients with nonsmall cell lung cancer during chemotherapy.
Naumnik W; Chyczewska E; Ossolinska M
Cancer Invest; 2009 Aug; 27(7):741-6. PubMed ID: 19340656
[TBL] [Abstract][Full Text] [Related]
10. The combination of intermediate doses of thalidomide and dexamethasone reduces bone marrow micro-vessel density but not serum levels of angiogenic cytokines in patients with refractory/relapsed multiple myeloma.
Hatjiharissi E; Terpos E; Papaioannou M; Hatjileontis C; Kaloutsi V; Galaktidou G; Gerotziafas G; Christakis J; Zervas K
Hematol Oncol; 2004 Dec; 22(4):159-68. PubMed ID: 15991268
[TBL] [Abstract][Full Text] [Related]
11. Normalization of the serum angiopoietin-1 to angiopoietin-2 ratio reflects response in refractory/resistant multiple myeloma patients treated with bortezomib.
Anargyrou K; Terpos E; Vassilakopoulos TP; Pouli A; Sachanas S; Tzenou T; Masouridis S; Christoulas D; Angelopoulou MK; Dimitriadou EM; Kalpadakis C; Tsionos K; Panayiotidis P; Dimopoulos MA; Pangalis GA; Kyrtsonis MC;
Haematologica; 2008 Mar; 93(3):451-4. PubMed ID: 18287135
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of angiopoietin-2 are associated with the growth of multiple myeloma.
Pappa CA; Tsirakis G; Samiotakis P; Tsigaridaki M; Alegakis A; Goulidaki N; Alexandrakis MG
Cancer Invest; 2013 Jul; 31(6):385-9. PubMed ID: 23758184
[TBL] [Abstract][Full Text] [Related]
13. Angiopoietin-2 in Bone Marrow milieu promotes Multiple Myeloma-associated angiogenesis.
Belloni D; Marcatti M; Ponzoni M; Ciceri F; Veschini L; Corti A; Caligaris Cappio F; Ferrarini M; Ferrero E
Exp Cell Res; 2015 Jan; 330(1):1-12. PubMed ID: 25447443
[TBL] [Abstract][Full Text] [Related]
14. Preoperative angiopoietin-2 serum levels: a marker of malignant potential in ovarian neoplasms and poor prognosis in epithelial ovarian cancer.
Sallinen H; Heikura T; Laidinen S; Kosma VM; Heinonen S; Ylä-Herttuala S; Anttila M
Int J Gynecol Cancer; 2010 Dec; 20(9):1498-505. PubMed ID: 21119365
[TBL] [Abstract][Full Text] [Related]
15. Angiogenic cytokines profile in smoldering multiple myeloma: no difference compared to MGUS but altered compared to symptomatic myeloma.
Gkotzamanidou M; Christoulas D; Souliotis VL; Papatheodorou A; Dimopoulos MA; Terpos E
Med Sci Monit; 2013 Dec; 19():1188-94. PubMed ID: 24355943
[TBL] [Abstract][Full Text] [Related]
16. Angiopoietin-2 as a Prognostic Factor in Patients with Incurable Stage IV Colorectal Cancer.
Munakata S; Ueyama T; Ishihara H; Komiyama H; Tsukamoto R; Kawai M; Takahashi M; Kojima Y; Tomiki Y; Sakamoto K
J Gastrointest Cancer; 2021 Mar; 52(1):237-242. PubMed ID: 32166589
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters.
Bhatti SS; Kumar L; Dinda AK; Dawar R
Am J Hematol; 2006 Sep; 81(9):649-56. PubMed ID: 16845660
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-10 Induces Both Plasma Cell Proliferation and Angiogenesis in Multiple Myeloma.
Alexandrakis MG; Goulidaki N; Pappa CA; Boula A; Psarakis F; Neonakis I; Tsirakis G
Pathol Oncol Res; 2015 Sep; 21(4):929-34. PubMed ID: 25743259
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy.
Kumar S; Gertz MA; Dispenzieri A; Lacy MQ; Wellik LA; Fonseca R; Lust JA; Witzig TE; Kyle RA; Greipp PR; Rajkumar SV
Bone Marrow Transplant; 2004 Aug; 34(3):235-9. PubMed ID: 15170170
[TBL] [Abstract][Full Text] [Related]
20. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
Nadar SK; Blann A; Beevers DG; Lip GY
J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
